Auteurs
Exploration
Accueil
Racine
Exploration
Accueil
Racine

Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « Auteurs » - entrée « Tsutomu Takeuchi »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Tsutomu Shinohara < Tsutomu Takeuchi < Tsuyoshi Igarashi  Facettes :

List of bibliographic references indexed by Tsutomu Takeuchi

Number of relevant bibliographic references: 59.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000044 (2020) Ernest H. Choy [Royaume-Uni] ; Fabrizio De Benedetti [Italie] ; Tsutomu Takeuchi [Japon] ; Misato Hashizume [Japon] ; Markus R. John [Suisse] ; Tadamitsu Kishimoto [Japon]Translating IL-6 biology into effective treatments
000063 (2020) Mitsuhiro Akiyama [Japon] ; Yuko Kaneko [Japon] ; Tsutomu Takeuchi [Japon]Tocilizumab in isolated polymyalgia rheumatica: A systematic literature review.
000168 (2020) Tsutomu Takeuchi [Japon] ; Yoshiya Tanaka [Japon] ; Sakae Tanaka [Japon] ; Atsushi Kawakami [Japon] ; Yeong-Wook Song [Corée du Sud] ; Yi-Hsing Chen [Taïwan] ; Mitsuhiro Rokuda [Japon] ; Hiroyuki Izutsu [Japon] ; Satoshi Ushijima [Japon] ; Yuichiro Kaneko [Japon] ; Yoshihiro Nakashima [Japon] ; Teruaki Shiomi [Japon] ; Emi Yamada [Japon]Safety and effectiveness of peficitinib (ASP015K) in patients with rheumatoid arthritis: interim data (22.7 months mean peficitinib treatment) from a long-term, open-label extension study in Japan, Korea, and Taiwan
000190 (2020) Yuko Kaneko [Japon] ; Hideto Kameda [Japon] ; Kei Ikeda [Japon] ; Tomonori Ishii [Japon] ; Kosaku Murakami [Japon] ; Hyota Takamatsu [Japon] ; Yoshiya Tanaka [Japon] ; Takayuki Abe [Japon] ; Tsutomu Takeuchi [Japon]Response to: 'Some concerns from Turkey' by Bilgin et al.
000429 (2020) Josef S. Smolen [Autriche] ; Robert B M. Landewé [Pays-Bas] ; Johannes W J. Bijlsma [Pays-Bas] ; Gerd R. Burmester [Allemagne] ; Maxime Dougados [France] ; Andreas Kerschbaumer [Autriche] ; Iain B. Mcinnes [Royaume-Uni] ; Alexandre Sepriano [Pays-Bas] ; Ronald F. Van Vollenhoven [Pays-Bas] ; Maarten De Wit [Pays-Bas] ; Daniel Aletaha [Autriche] ; Martin Aringer [Allemagne] ; John Askling [Suède] ; Alejandro Balsa [Espagne] ; Maarten Boers [Pays-Bas] ; Alfons A. Den Broeder [Pays-Bas] ; Maya H. Buch [Royaume-Uni] ; Frank Buttgereit [Allemagne] ; Roberto Caporali [Italie] ; Mario Humberto Cardiel [Mexique] ; Diederik De Cock [Belgique] ; Catalin Codreanu [Roumanie] ; Maurizio Cutolo [Italie] ; Christopher John Edwards [Royaume-Uni] ; Yvonne Van Eijk-Hustings [Pays-Bas] ; Paul Emery [Royaume-Uni] ; Axel Finckh [Suisse] ; Laure Gossec [France] ; Jacques-Eric Gottenberg [France] ; Merete Lund Hetland [Danemark] ; Tom W J. Huizinga [Pays-Bas] ; Marios Koloumas [Suisse] ; Zhanguo Li [République populaire de Chine] ; Xavier Mariette [France] ; Ulf Müller-Ladner [Allemagne] ; Eduardo F. Mysler [Argentine] ; Jose A P. Da Silva [Portugal] ; Gyula Po R [Hongrie] ; Janet E. Pope [Canada] ; Andrea Rubbert-Roth [Suisse] ; Adeline Ruyssen-Witrand [France] ; Kenneth G. Saag [États-Unis] ; Anja Strangfeld [Allemagne] ; Tsutomu Takeuchi [Japon] ; Marieke Voshaar [Pays-Bas] ; René Westhovens [Belgique] ; Désirée Van Der Heijde [Pays-Bas]EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update.
000562 (2020) Hiroki Yamada [Japon] ; Yuko Kaneko [Japon] ; Hiroya Tamai [Japon] ; Tsutomu Takeuchi [Japon]Biomarkers for disease flare in patients with adult-onset Still's disease undergoing treatment with tocilizumab.
000572 (2020) Takahiko Sugihara [Japon] ; Hitoshi Hasegawa ; Haruhito A. Uchida [Japon] ; Hajime Yoshifuji [Japon] ; Yoshiko Watanabe [Japon] ; Eisuke Amiya [Japon] ; Yasuhiro Maejima [Japon] ; Masanori Konishi [Japon] ; Yohko Murakawa [Japon] ; Noriyoshi Ogawa [Japon] ; Shunsuke Furuta [Japon] ; Yasuhiro Katsumata [Japon] ; Yoshinori Komagata [Japon] ; Taio Naniwa [Japon] ; Takahiro Okazaki [Japon] ; Yoshiya Tanaka [Japon] ; Tsutomu Takeuchi [Japon] ; Yoshikazu Nakaoka [Japon] ; Yoshihiro Arimura [Japon] ; Masayoshi Harigai [Japon] ; Mitsuaki Isobe [Japon]Associated factors of poor treatment outcomes in patients with giant cell arteritis: clinical implication of large vessel lesions
000844 (2019) Kotaro Matsumoto [Japon] ; Katsuya Suzuki [Japon] ; Keiko Yoshimoto [Japon] ; Noriyasu Seki ; Hideto Tsujimoto ; Kenji Chiba ; Tsutomu Takeuchi [Japon]Significant association between clinical characteristics and changes in peripheral immuno-phenotype in large vessel vasculitis
000905 (2019) Yuko Kaneko [Japon] ; Hideto Kameda [Japon] ; Kei Ikeda [Japon] ; Tomonori Ishii [Japon] ; Kosaku Murakami [Japon] ; Hyota Takamatsu [Japon] ; Yoshiya Tanaka [Japon] ; Takayuki Abe [Japon] ; Tsutomu Takeuchi [Japon]Response to: 'Tocilizumab in patients with adult-onset Still's disease refractory to glucocorticoid treatment' by Lee.
000965 (2019) Masaru Kato [Japon] ; Yuko Kaneko [Japon] ; Yoshiya Tanaka [Japon] ; Masayuki Inoo [Japon] ; Hitomi Kobayashi-Haraoka [Japon] ; Koichi Amano [Japon] ; Masayuki Miyata [Japon] ; Yohko Murakawa [Japon] ; Hidekata Yasuoka [Japon] ; Shintaro Hirata [Japon] ; Hayato Nagasawa [Japon] ; Eiichi Tanaka [Japon] ; Nobuyuki Miyasaka [Japon] ; Hisashi Yamanaka [Japon] ; Kazuhiko Yamamoto [Japon] ; Isao Yokota [Japon] ; Tatsuya Atsumi [Japon] ; Tsutomu Takeuchi [Japon]Predictive value of serum amyloid a levels for requirement of concomitant methotrexate in tocilizumab initiation: A post hoc analysis of the SURPRISE study.
000A58 (2019) Masaru Takeshita [Japon] ; Katsuya Suzuki [Japon] ; Yasushi Kondo [Japon] ; Rimpei Morita [Japon] ; Yuumi Okuzono [Japon] ; Keiko Koga [Japon] ; Yoshiaki Kassai [Japon] ; Kanae Gamo [Japon] ; Maiko Takiguchi [Japon] ; Rina Kurisu [Japon] ; Hideyuki Mototani [Japon] ; Yukihiko Ebisuno [Japon] ; Akihiko Yoshimura [Japon] ; Tsutomu Takeuchi [Japon]Multi-dimensional analysis identified rheumatoid arthritis-driving pathway in human T cell
000C08 (2019) Shuntaro Saito ; Tsutomu TakeuchiImmune response in LPD during methotrexate administration (MTX-LPD) in rheumatoid arthritis patients
000D22 (2019) Tsutomu Takeuchi [Japon] ; Yoshiya Tanaka [Japon] ; Sakae Tanaka [Japon] ; Atsushi Kawakami [Japon] ; Manabu Iwasaki [Japon] ; Kou Katayama [Japon] ; Mitsuhiro Rokuda [Japon] ; Hiroyuki Izutsu [Japon] ; Satoshi Ushijima [Japon] ; Yuichiro Kaneko [Japon] ; Teruaki Shiomi [Japon] ; Emi Yamada [Japon] ; Désirée Van Der Heijde [Pays-Bas]Efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase III randomised, double-blind, placebo-controlled trial (RAJ4) in Japan
000F05 (2019) Peter C. Taylor ; Michael E. Weinblatt ; Gerd R. Burmester ; Terence P. Rooney ; Sarah Witt ; Chad D. Walls ; Maher Issa ; Claudia A. Salinas ; Chadi Saifan ; Xin Zhang ; Anabela Cardoso ; Miguel A. González-Gay ; Tsutomu TakeuchiCardiovascular Safety During Treatment With Baricitinib in Rheumatoid Arthritis
001129 (2018) Yuko Kaneko [Japon] ; Hideto Kameda [Japon] ; Kei Ikeda [Japon] ; Tomonoti Ishii [Japon] ; Kosaku Murakami [Japon] ; Hyota Takamatsu [Japon] ; Yoshiya Tanaka [Japon] ; Takayuki Abe [Japon] ; Tsutomu Takeuchi [Japon]Tocilizumab in patients with adult-onset still's disease refractory to glucocorticoid treatment: a randomised, double-blind, placebo-controlled phase III trial.
001141 (2018) Yuko Kaneko [Japon] ; Masaru Kato [Japon] ; Yoshiya Tanaka [Japon] ; Masayuki Inoo [Japon] ; Hitomi Kobayashi-Haraoka [Japon] ; Koichi Amano [Japon] ; Masayuki Miyata [Japon] ; Yohko Murakawa [Japon] ; Hidekara Yasuoka [Japon] ; Shintaro Hirata [Japon] ; Eiichi Tanaka [Japon] ; Nobuyuki Miyasaka [Japon] ; Hisashi Yamanaka [Japon] ; Kazuhiko Yamamoto [Japon] ; Tsutomu Takeuchi [Japon]Tocilizumab discontinuation after attaining remission in patients with rheumatoid arthritis who were treated with tocilizumab alone or in combination with methotrexate: results from a prospective randomised controlled study (the second year of the SURPRISE study).
001285 (2018) Shinya Tasaki [Japon] ; Katsuya Suzuki [Japon] ; Yoshiaki Kassai [Japon] ; Masaru Takeshita [Japon] ; Atsuko Murota [Japon] ; Yasushi Kondo [Japon] ; Tatsuya Ando [Japon] ; Yusuke Nakayama [Japon] ; Yuumi Okuzono [Japon] ; Maiko Takiguchi [Japon] ; Rina Kurisu [Japon] ; Takahiro Miyazaki [Japon] ; Keiko Yoshimoto [Japon] ; Hidekata Yasuoka [Japon] ; Kunihiro Yamaoka [Japon] ; Rimpei Morita [Japon] ; Akihiko Yoshimura [Japon] ; Hiroyoshi Toyoshiba [Japon] ; Tsutomu Takeuchi [Japon]Multi-omics monitoring of drug response in rheumatoid arthritis in pursuit of molecular remission.
001557 (2017) Shuntaro Saito [Japon] ; Yuko Kaneko [Japon] ; Keisuke Izumi [Japon] ; Tsutomu Takeuchi [Japon]Utility of Dose Frequency Adjustment in Tocilizumab Administration for Rheumatoid Arthritis.
001777 (2017) Mitsuhiro Akiyama [Japon] ; Hidekata Yasuoka [Japon] ; Tsutomu Takeuchi [Japon]Interleukin-6 in idiopathic multicentric Castleman's disease after long-term tocilizumab.
001833 (2017) Naoki Ishiguro [Japon] ; Tatsuya Atsumi [Japon] ; Masayoshi Harigai [Japon] ; Tsuneyo Mimori [Japon] ; Norihiro Nishimoto [Japon] ; Takayuki Sumida [Japon] ; Tsutomu Takeuchi [Japon] ; Yoshiya Tanaka [Japon] ; Ayako Nakasone [Japon] ; Nobuhiro Takagi ; Hisashi Yamanaka [Japon]Effectiveness and safety of tocilizumab in achieving clinical and functional remission, and sustaining efficacy in biologics-naive patients with rheumatoid arthritis: The FIRST Bio study.
001837 (2017) Josef S. Smolen [Autriche] ; Robert Landewé [Pays-Bas] ; Johannes Bijlsma [Pays-Bas] ; Gerd Burmester [Allemagne] ; Katerina Chatzidionysiou [Suède] ; Maxime Dougados [France] ; Jackie Nam [Royaume-Uni] ; Sofia Ramiro [Pays-Bas] ; Marieke Voshaar [Pays-Bas] ; Ronald Van Vollenhoven [Pays-Bas] ; Daniel Aletaha [Autriche] ; Martin Aringer [Allemagne] ; Maarten Boers [Pays-Bas] ; Chris D. Buckley [Royaume-Uni] ; Frank Buttgereit [Allemagne] ; Vivian Bykerk [États-Unis] ; Mario Cardiel [Mexique] ; Bernard Combe [France] ; Maurizio Cutolo [Italie] ; Yvonne Van Eijk-Hustings [Pays-Bas] ; Paul Emery [Pays-Bas] ; Axel Finckh [Suisse] ; Cem Gabay [Suisse] ; Juan Gomez-Reino [Espagne] ; Laure Gossec [France] ; Jacques-Eric Gottenberg [France] ; Johanna M W. Hazes [Pays-Bas] ; Tom Huizinga [Pays-Bas] ; Meghna Jani [Royaume-Uni] ; Dmitry Karateev [Russie] ; Marios Kouloumas [Suisse] ; Tore Kvien [Norvège] ; Zhanguo Li [République populaire de Chine] ; Xavier Mariette [France] ; Iain Mcinnes [Royaume-Uni] ; Eduardo Mysler [Argentine] ; Peter Nash [Australie] ; Karel Pavelka [République tchèque] ; Gyula Po R [Hongrie] ; Christophe Richez [France] ; Piet Van Riel [Pays-Bas] ; Andrea Rubbert-Roth [Allemagne] ; Kenneth Saag [États-Unis] ; Jose Da Silva [Portugal] ; Tanja Stamm [Autriche] ; Tsutomu Takeuchi [Japon] ; René Westhovens [Belgique] ; Maarten De Wit [Pays-Bas] ; Désirée Van Der Heijde [Pays-Bas]EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i -k "Tsutomu Takeuchi" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i  \
                -Sk "Tsutomu Takeuchi" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Author.i
   |clé=    Tsutomu Takeuchi
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021